本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioCryst製藥

8.05
+0.07000.88%
盤後8.050.0001+0.00%17:43 EDT
成交量:348.10萬
成交額:2,797.52萬
市值:16.82億
市盈率:-18.72
高:8.12
開:8.09
低:7.94
收:7.98
資料載入中...

公司資料

公司名字:
BioCryst製藥
交易所:
NASDAQ
成立時間:
1986
員工人數:
580
公司地址:
4505 Emperor Boulevard,Suite 200,Durham,North Carolina,United States
郵編:
27703
電話:
傳真:
919 859 1314
簡介:
BioCryst Pharmaceuticals, Inc.是一家特拉華州公司,最初成立於1986年。該公司是一家全球性生物技術公司,致力於改善遺傳性血管性水腫和罕見病患者的生活。該公司利用結構引導藥物設計方面的專業知識,目標是開發一流或一流的口服小分子和注射蛋白療法,以針對難以治療的罕見疾病。

董事

名稱
職位
Jon P. Stonehouse
Director, President and Chief Executive Officer
Robert A. Ingram
Director and Chairman of the Board
Fred E. Cohen
Director
George B. Abercrombie
Director
Kenneth B. Lee, Jr.
Director
Nancy J. Hutson
Director
Stanley C. Erck
Director

股東

名稱
職位
Jon P. Stonehouse
Director, President and Chief Executive Officer
Lynne Powell
Senior Vice President and Chief Commercial Officer
Thomas R. Staab II
Senior Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer
William P. Sheridan
Senior Vice President and Chief Medical Officer
Yarlagadda S. Babu
Senior Vice President of Drug Discovery
Alane P. Barnes
Vice President, General Counsel and Corporate Secretary